Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial

Treatment of secondary (or functional) mitral regurgitation had traditionally been limited to optimal medical therapy because studies have failed to show a survival benefit with mitral valve surgery for this condition. However, recently the Cardiovascular Outcomes Assessment of the MitraClip Percuta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Suzanne J Baron
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2020
Materias:
Acceso en línea:https://doaj.org/article/e0e84d83a3ef428481b119afc5e50faf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares